Loading…
T2 and T2 mapping in patients after matrix-associated autologous chondrocyte transplantation: initial results on clinical use with 3.0-Tesla MRI
Objectives To use T2 and T2* mapping in patients after matrix-associated autologous chondrocyte transplantation (MACT) of the knee, and to compare and correlate both methodologies. Methods 3.0-Tesla MRI was performed on 30 patients (34.6 ± 9.9 years) with a follow-up period of 28.1 ± 18.8 months aft...
Saved in:
Published in: | European radiology 2010-06, Vol.20 (6), p.1515-1523 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
To use T2 and T2* mapping in patients after matrix-associated autologous chondrocyte transplantation (MACT) of the knee, and to compare and correlate both methodologies.
Methods
3.0-Tesla MRI was performed on 30 patients (34.6 ± 9.9 years) with a follow-up period of 28.1 ± 18.8 months after MACT. Multi-echo, spin-echo-based T2 mapping using six echoes and gradient-echo-based T2* mapping using six echoes were prepared. T2 and T2* maps were obtained using a pixel-wise, mono-exponential, non-negative least-squares fit analysis. Region-of-interest analysis was performed for mean (full-thickness) as well as deep and superficial aspects of the cartilage repair tissue and control cartilage sites.
Results
Mean T2 values (ms) were comparable for the control cartilage (53.4 ± 11.7) and the repair tissue (55.5 ± 11.6) (
p
> 0.05). Mean T2* values (ms) for control cartilage (30.9 ± 6.6) were significantly higher than those of the repair tissue (24.5 ± 8.1) (
p
|
---|---|
ISSN: | 0938-7994 1432-1084 |
DOI: | 10.1007/s00330-009-1669-y |